Top

Cardiovascular Ultrasound

Published in:

Open Access 01-12-2020 | Transesophageal Echocardiography | Research

Left atrial spontaneous echo contrast occurring in patients with low CHADS₂ or CHA₂DS₂-VASc scores

Authors: Kanako Akamatsu, Takahide Ito, Michishige Ozeki, Masatoshi Miyamura, Koichi Sohmiya, Masaaki Hoshiga

Published in: Cardiovascular Ultrasound | Issue 1/2020

Abstract

Background

Left atrial spontaneous echo contrast (LASEC) is common in patients with atrial fibrillation (AF), although scarce information exists on LASEC occurring in nonvalvular AF patients who have low thromboembolic risk scores. We therefore examined prevalence and determinants of LASEC under low CHADS₂ or CHA₂DS₂-VASc scores in these patients.

Methods

Among 713 patients who underwent transesophageal echocardiography, 349 with a CHADS₂ score < 2 (CHADS₂ group) (93 women, mean age 65 years) and 221 with a CHA₂DS₂-VASc score < 2 (CHA₂DS₂-VASc group) (39 women, mean age 62 years) were separately examined for clinical and echocardiographic findings.

Results

LASEC was found in 77 patients of CHADS₂ group (22%) and in 41 of CHA₂DS₂-VASc group (19%). Multivariate logistic regression analysis, adjusted for several parameters including non-paroxysmal AF, LA enlargement (LA diameter ≥ 50 mm), left ventricular (LV) hypertrophy, and an elevated B-type natriuretic peptide (BNP) (BNP ≥200 pg/mL) revealed that for CHADS₂ group, non-paroxysmal AF (Odds ratio 5.65, 95%CI 3.08–10.5, P < 0.001), BNP elevation (Odds ratio 3.42, 95%CI 1.29–9.06, P = 0.013), and LV hypertrophy (Odds ratio 2.26, 95%CI 1.19–4.28, P = 0.013) were significant independent determinants of LASEC, and that for CHA₂DS₂-VASc group, non-paroxysmal AF (Odds ratio 3.38, 95%CI 1.51–7.54, P = 0.003) and LV hypertrophy (Odds ratio 2.53, 95%CI 1.13–5.70, P = 0.025) were significant independent determinants of LASEC.

Conclusions

LASEC was present in a considerable proportion of patients with nonvalvular AF under low thromboembolic risk scores. Information on AF chronicity, BNP, and LV hypertrophy might help identify patients at risk for thromboembolism, although large-scale studies are necessary to confirm our observations.

Leung DY, Black IW, Cranney GB, Hopkins AP, Walsh WF. Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. J Am Coll Cardiol. 1994;24:755–62. https://doi.org/10.1016/0735-1097(94)90025-6.CrossRefPubMed

Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The stroke prevention in atrial fibrillation investigators committee on echocardiography. Ann Intern Med. 1998;128:639–47.

Black IW, Hopkins AP, Lee LC, Walsh WF. Left atrial spontaneous echo contrast: a clinical and echocardiographic analysis. J Am Coll Cardiol. 1991;18:398–404. https://doi.org/10.1016/0735-1097(91)90592-w.CrossRefPubMed

Miyazaki S, Ito T, Suwa M, Nakamura T, Kobashi A, Kitaura Y. Role of transesophageal echocardiography in the prediction of thromboembolism in patients with chronic nonvalvular atrial fibrillation. Jpn Circ J. 2001;65:874–8. https://doi.org/10.1253/jcj.65.874.CrossRefPubMed

Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst SV, et al. Guidelines for the management of atrial fibrillation: the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369–429. https://doi.org/10.1093/eurheartj/ehq278.CrossRefPubMed

Puwanant S, Varr BC, Shrestha K, Hussain SK, Tang WH, Gabriel RS, et al. Role of the CHADS2 score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation. J Am Coll Cardiol. 2009;54:2032–9. https://doi.org/10.1016/j.jacc.2009.07.037.CrossRefPubMed

Zhang E, Liu T, Li Z, Zhao J, Li G. High CHA2DS2-VASc score predicts left atrial thrombus or spontaneous echo contrast detected by transesophageal echocardiography. Int J Cardiol. 2015;184:540–2. https://doi.org/10.1016/j.ijcard.2015.02.109.CrossRefPubMed

Willens HJ, Gómez-Marín O, Nelson K, DeNicco A, Moscucci M. Correlation of CHADS2 and CHA2DS2-VASc scores with transesophageal echocardiography risk factors for thromboembolism in a multiethnic United States population with nonvalvular atrial fibrillation. J Am Soc Echocardiogr. 2013;26:175–84. https://doi.org/10.1016/j.echo.2012.11.002.CrossRefPubMed

Yao Y, Shang MS, Gao LJ, Zhao JH, Yang XH, Liu T. Elevated homocysteine increases the risk of left atrial/left atrial appendage thrombus in non-valvular atrial fibrillation with low CHA2DS2-VASc score. Europace. 2018;20:1093–8. https://doi.org/10.1093/europace/eux189.CrossRefPubMed

10.

Yoshida N, Okamoto M, Hirao H, Nanba K, Kinoshita H, Matsumura H, et al. Role of transthoracic left atrial appendage wall motion velocity in patients with persistent atrial fibrillation and a low CHADS2 score. J Cardiol. 2012;60:310–5. https://doi.org/10.1016/j.jjcc.2012.05.007.CrossRefPubMed

11.

Doukky R, Gage H, Nagarajan V, Demopoulos A, Cena M, Garcia-Sayan E, et al. B-type natriuretic peptide predicts left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Echocardiography. 2013;30:889–95. https://doi.org/10.1111/echo.12169.CrossRefPubMed

12.

Iwakura K, Okamura A, Koyama Y, Date M, Higuchi Y, Inoue K, et al. Effect of elevated left ventricular diastolic filling pressure on the frequency of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Am J Cardiol. 2011;107:417–22. https://doi.org/10.1016/j.amjcard.2010.09.042.CrossRefPubMed

13.

Fatkin D, Kelly RP, Feneley MP. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol. 1994;23:961–9. https://doi.org/10.1016/0735-1097(94)90644-0.CrossRefPubMed

14.

Black IW, Chesterman CN, Hopkins AP, Lee LC, Chong BH, Walsh WF. Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation. J Am Coll Cardiol. 1993;21:451–7. https://doi.org/10.1016/0735-1097(93)90688-w.CrossRefPubMed

15.

Rader VJ, Khumri TM, Idupulapati M, Stoner CN, Magalski A, Main ML. Clinical predictors of left atrial thrombus and spontaneous echocardiographic contrast in patients with atrial fibrillation. J Am Soc Echocardiogr. 2007;20:1181–5. https://doi.org/10.1016/j.echo.2007.02.010.CrossRefPubMed

16.

Siostrzonek P, Koppensteiner R, Gössinger H, Zangeneh M, Heinz G, Kreiner G, et al. Hemodynamic and hemorheologic determinants of left atrial spontaneous echo contrast and thrombus formation in patients with idiopathic dilated cardiomyopathy. Am Heart J. 1993;125(2 Pt 1):430–4. https://doi.org/10.1016/0002-8703(93)90022-2.CrossRefPubMed

17.

Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233–70. https://doi.org/10.1093/ehjci/jev014.CrossRefPubMed

18.

Orsinelli DA, Pearson AC. Usefulness of multiplane transesophageal echocardiography in differentiating left atrial appendage thrombus from pectinate muscles. Am Heart J. 1996;131:622–3. https://doi.org/10.1016/s0002-8703(96)90553-0.CrossRefPubMed

19.

Daniel WG, Nellessen U, Schröder E, Nonnast-Daniel B, Bednarski P, Nikutta P, et al. Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk. J Am Coll Cardiol. 1988;11:1204–11. https://doi.org/10.1016/0735-1097(88)90283-5.CrossRefPubMed

20.

Beppu S, Nimura Y, Sakakibara H, Nagata S, Park YD, Izumi S. Smoke-like echo in the left atrial cavity in mitral valve disease: its features and significance. J Am Coll Cardiol. 1985;6:744–9. https://doi.org/10.1016/S0735-1097(85)80476-9.CrossRefPubMed

21.

Eckman MH, Singer DE, Rosand J, Greenberg SM. Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes. 2011;4:14–21. https://doi.org/10.1161/CIRCOUTCOMES.110.958108.CrossRefPubMed

22.

Clark CB, Telles Garcia NA, Hackett Renner C, Ryan SM. Correlation of left atrial appendage ejection velocities with the CHADS2 and CHA2DS2-VASc scores. Echocardiography. 2016;33(8):1195–201. https://doi.org/10.1111/echo.13228.CrossRefPubMed

23.

Lip GY, Frison L, Halperin JL, Lane DA. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation. J Am Coll Cardiol. 2011;57:173–80. https://doi.org/10.1016/j.jacc.2010.09.024.CrossRefPubMed

24.

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1–266.

25.

Zabalgoitia M, Halperin JL, Pearce LA, Blackshear JL, Asinger RW, Hart RG. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke prevention in atrial fibrillation III investigators. J Am Coll Cardiol. 1998;31:1622–6. https://doi.org/10.1016/s0735-1097(98)00146-6.CrossRefPubMed

26.

Maehama T, Okura H, Imai K, Yamada R, Obase K, Saito K, et al. Usefulness of CHADS2 score to predict C-reactive protein, left atrial blood stasis, and prognosis in patients with nonrheumatic atrial fibrillation. Am J Cardiol. 2010;106:535–8. https://doi.org/10.1016/j.amjcard.2010.03.067.CrossRefPubMed

27.

Yashiro Y, Arimoto T, Hashimoto N, Tamura H, Iwayama T, Ishigaki D, et al. Predictors of left atrial coagulation activity among paroxysmal atrial fibrillation patients. Circ J. 2015;79(1):61–9. https://doi.org/10.1253/circj.CJ-14-0630.CrossRefPubMed

28.

Ito T, Suwa M. Left atrial spontaneous echo contrast: relationship with clinical and echocardiographic parameters. Echo Res Pract. 2019;6:R65–73. https://doi.org/10.1530/ERP-18-0083.CrossRefPubMedPubMedCentral

29.

Kimura T, Takatsuki S, Inagawa K, Katsumata Y, Nishiyama T, Nishiyama N, et al. Anatomical characteristics of the left atrial appendage in cardiogenic stroke with low CHADS2 scores. Heart Rhythm. 2013;10:921–5. https://doi.org/10.1016/j.hrthm.2013.01.036.CrossRefPubMed

30.

Seko Y, Kato T, Haruna T, Izumi T, Miyamoto S, Nakane E, et al. Association between atrial fibrillation, atrial enlargement, and left ventricular geometric remodeling. Sci Rep. 2018;8:6366. https://doi.org/10.1038/s41598-018-24875-1.CrossRefPubMedPubMedCentral

31.

Agmon Y, Khandheria BK, Gentile F, Gentile F, Seward JB. Echocardiographic assessment of the left atrial appendage. J Am Coll Cardiol. 1999;34:1867–77. https://doi.org/10.1016/s0735-1097(99)00472-6.CrossRefPubMed

32.

Mitusch R, Garbe M, Schmucker G, Schwabe K, Stierle U, Sheikhzadeh A, et al. Relation of left atrial appendage function to the duration and reversibility of nonvalvular atrial fibrillation. Am J Cardiol. 1995;75:944–7. https://doi.org/10.1016/s0002-9149(99)80695-x.CrossRefPubMed

Title: Left atrial spontaneous echo contrast occurring in patients with low CHADS2 or CHA2DS2-VASc scores
Authors: Kanako Akamatsu
Takahide Ito
Michishige Ozeki
Masatoshi Miyamura
Koichi Sohmiya
Masaaki Hoshiga
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Transesophageal Echocardiography
Atrial Fibrillation
Published in: Cardiovascular Ultrasound / Issue 1/2020
Electronic ISSN: 1476-7120
DOI: https://doi.org/10.1186/s12947-020-00213-2

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Left atrial spontaneous echo contrast occurring in patients with low CHADS₂ or CHA₂DS₂-VASc scores

Abstract

Background

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2020

Assessment of left ventricular systolic function by non-invasive pressure-strain loop area in young male strength athletes

Global longitudinal strain correlates to systemic right ventricular function

Myocarditis successfully diagnosed and controlled with speckle tracking echocardiography

Prognostic implications of tricuspid annular plane systolic excursion/pulmonary arterial systolic pressure ratio in septic shock patients

Feasibility and accuracy of a novel automated three-dimensional ultrasonographic analysis system for abdominal aortic aneurysm: comparison with two-dimensional ultrasonography and computed tomography

Local myocardial stiffness variations identified by high frame rate shear wave echocardiography

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page